CN102895452A - Oral medicinal liquor for treatment of liver depression and qi stagnation type chloasma - Google Patents
Oral medicinal liquor for treatment of liver depression and qi stagnation type chloasma Download PDFInfo
- Publication number
- CN102895452A CN102895452A CN2012103577596A CN201210357759A CN102895452A CN 102895452 A CN102895452 A CN 102895452A CN 2012103577596 A CN2012103577596 A CN 2012103577596A CN 201210357759 A CN201210357759 A CN 201210357759A CN 102895452 A CN102895452 A CN 102895452A
- Authority
- CN
- China
- Prior art keywords
- treatment
- medicinal liquor
- liver
- stagnation
- liquor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicinal liquor, i.e. an oral medicinal liquor for treatment of liver depression and qi stagnation type chloasma. The medicinal liquor is made from the following raw materials: 20-25g of rhizoma cyperi, 20-25g of radix bupleuri, 15-18g of murraya paniculata, 15-18g of miscanthus gall, 35-40g of Inula cappa, 35-40g of mallotus roots, and 1000-1200ml of 50-degree liquor. The medicinal liquor has the characteristics of new formula, low cost, small toxic and side effect, and good curative effect.
Description
Technical field:
The present invention relates to a kind of Chinese medicine tincture, i.e. a kind of oral medicinal liquor for the treatment of stagnation of liver-qi type chloasma.
Background technology:
Chloasma is commonly called as butterfly spot, is to betide facial a kind of chromatopathy, common women.Its cause of disease is comparatively complicated, and it is generally acknowledged may be relevant with endocrine.The Symptoms of stagnation of liver-qi type chloasma is: facial brown macules is symmetrical, and size is indefinite, clear-cut margin, and with distending pain over the hypochondrium, irritated irritability, menoxenia etc.At present, the medicine of state's internal therapy stagnation of liver-qi type chloasma is more, mainly take Western medicine as main, but has the shortcomings such as medical expense is high, therapeutic effect is satisfied not.
Summary of the invention:
The objective of the invention is to use the existing weak point of medicine for present treatment stagnation of liver-qi type chloasma, and a kind of oral medicinal liquor for the treatment of stagnation of liver-qi type chloasma is provided.
Technical scheme of the present invention is achieved in that
A kind of oral medicinal liquor for the treatment of stagnation of liver-qi type chloasma, this medicated wine is made by following raw material: Rhizoma Cyperi, each 20-25 gram of Radix Bupleuri, Folium Et Cacumen Murrayae, each 15-18 gram of Caulis Miscanthis floriduli, Herba Inulae cappae, each 35-40 gram of Radix Malloti Apelitae, 50 ° of Chinese liquor 1000-1200 milliliters.
A kind of oral medicinal liquor for the treatment of stagnation of liver-qi type chloasma, the preparation method of this medicated wine is: first said ratio amount raw material of Chinese medicine is processed into coarser powder, wraps with cloth and put into vial, then add 50 ° of Chinese liquor of proportional quantity, the cover lid sealing.After soak 20 days, filter and remove residue is got wine.
A kind of oral medicinal liquor for the treatment of stagnation of liver-qi type chloasma, the medicinal liquor prescription cost of material is cheap, and feeding is easy, can reduce medical expense, alleviates patient economy burden.
A kind of oral medicinal liquor for the treatment of stagnation of liver-qi type chloasma, it is stagnant that its treatment thinking is that dispersing the stagnated live-QI to relieve the stagnation of QI, circulation of qi promoting disappear.Follow the property of medicine through belonging at composition of raw materials, lay particular stress on dispersing the stagnated live-QI to relieve the stagnation of QI, take into account whole machine balancing.Rhizoma Cyperi has depressed liver-energy dispersing and QI regulating, resolving depression, regulating menoxenia in the medicated wine, Radix Bupleuri has reconciling superficies and interior, soothing the liver yang invigorating effect, Folium Et Cacumen Murrayae has promoting flow of QI and blood, expelling wind and removing dampness effect, that Caulis Miscanthis floriduli has is pleasant, except stasis of blood effect, Herba Inulae cappae have dispel the wind, dampness removing, circulation of qi promoting, change stagnate effect, Radix Malloti Apelitae has dampness removing, repercussive effect, and Chinese liquor has promoting blood circulation, the effect of row medicine gesture.Above-mentioned raw material of Chinese medicine and Chinese liquor compatibility, efficacy enhanced by wine, wine helps the efficacy of a drug, thereby has effectively given play to dispersing the stagnated live-QI to relieve the stagnation of QI, circulation of qi promoting disappears stagnant effect, to reach the purpose of curing stagnation of liver-qi type chloasma.
The present invention has following features: prescription is new, cost is low, toxic and side effects is little, curative effect is better.
Using method:
1, this medicated wine is oral medicinal liquor.
2, consumption: take each consumption 10-15 milliliter every day 2 times.
3, Time of Administration: a.p respectively take once before the sleep with evening every day.
4, temperature control: decoction being taken warmly.
Points for attention:
1, medicated wine must be measured in accordance with regulations and take.Excessive use meeting liver injury, heart and nervous system also can bring out Other diseases.
2, anemia of pregnant woman, wet nurse and child patient should not be taken.
3, suffering from the people such as chronic nephritis, chronic colitis and hepatitis, liver cirrhosis, digestive system and ulcer, pulmonary tuberculosis, epilepsy, cardiac dysfunction, diabetes, apoplexy, hypertension forbids taking.
The specific embodiment:
Embodiment 1: a kind of material combination for the treatment of the oral medicinal liquor of stagnation of liver-qi type chloasma is: each 20 gram of Rhizoma Cyperi, Radix Bupleuri, Folium Et Cacumen Murrayae, each 15 gram of Caulis Miscanthis floriduli, Herba Inulae cappae, each 35 gram of Radix Malloti Apelitae, 1000 milliliters of 50 ° of Chinese liquor.The preparation method of this medicated wine is: first said ratio amount raw material of Chinese medicine is processed into coarser powder, wraps with cloth and put into vial, then add 50 ° of Chinese liquor of proportional quantity, the cover lid sealing.After soak 20 days, filter and remove residue is got wine.
Embodiment 2: a kind of material combination for the treatment of the oral medicinal liquor of stagnation of liver-qi type chloasma is: each 25 gram of Rhizoma Cyperi, Radix Bupleuri, Folium Et Cacumen Murrayae, each 18 gram of Caulis Miscanthis floriduli, Herba Inulae cappae, each 40 gram of Radix Malloti Apelitae, 1200 milliliters of 50 ° of Chinese liquor.The preparation method of this medicated wine is: first said ratio amount raw material of Chinese medicine is processed into coarser powder, wraps with cloth and put into vial, then add 50 ° of Chinese liquor of proportional quantity, the cover lid sealing.After soak 20 days, filter and remove residue is got wine.
Clinical therapeutic efficacy:
Experimentation: 2002 to 2005, adopt this technical scheme treatment stagnation of liver-qi type chloasma patient totally 22 examples.Minimum 18 years old of patient age, maximum 61 years old, wherein 30-50 year patient 15 examples accounted for 68%.The shortest person of sick time 1 month, elder 1 year half, wherein 17 routine sick times are between 1-6 month.By the technique scheme treatment, 20 days is a course for the treatment of, treats namely to stop two courses for the treatment of.
Diagnostic criteria: a kind of oral medicinal liquor for the treatment of stagnation of liver-qi type chloasma, the disease for the treatment of, its symptom is defined as: facial brown macules is symmetrical, and size is indefinite, clear-cut margin, and with distending pain over the hypochondrium, irritated irritability, menoxenia etc.
Curative effect judging standard: curative effect judges whether Main Basis disappears in this disease symptoms, specifically is divided into following three grades: recovery from illness---after the patient takes medicated wine, and all symptom complete obiterations of disease; Taking a turn for the better---after the patient took medicated wine, all symptom major parts of disease disappeared or obviously alleviate; Invalid---after the patient took medicated wine, all symptoms of disease had no to disappear.
Therapeutic outcome: with medicated wine of the present invention treatment stagnation of liver-qi type chloasma patient 22 examples, take wine recovery from illness in 15 days 1 example, take wine 16-20 days 4 examples of fully recovering, take wine 21-40 days 11 examples of fully recovering, take wine 6 examples that take a turn for the better after two courses for the treatment of.Cure rate is that cure rate is 72% in 22%, two course for the treatment of in one course for the treatment of, and effective percentage is 100%.The 17 routine patients of sick time between 1-6 month are wherein taking wine wherein 14 example recoveries from illness after two courses for the treatment of, and cure rate is 82%.The course of disease is 5 routine patients more than 6 months, takes two courses for the treatment of of wine, 2 example recoveries from illness, and cure rate is 40%.Analyze thus, medicated wine of the present invention will be better than the longer patient of the course of disease far away to the shorter patient treatment effect of the course of disease.
Claims (1)
1. oral medicinal liquor for the treatment of stagnation of liver-qi type chloasma, it is characterized in that this medicated wine made by following raw material: Rhizoma Cyperi, each 20-25 gram of Radix Bupleuri, Folium Et Cacumen Murrayae, each 15-18 gram of Caulis Miscanthis floriduli, Herba Inulae cappae, each 35-40 gram of Radix Malloti Apelitae, 50 ° of Chinese liquor 1000-1200 milliliters.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012103577596A CN102895452A (en) | 2012-09-14 | 2012-09-14 | Oral medicinal liquor for treatment of liver depression and qi stagnation type chloasma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012103577596A CN102895452A (en) | 2012-09-14 | 2012-09-14 | Oral medicinal liquor for treatment of liver depression and qi stagnation type chloasma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102895452A true CN102895452A (en) | 2013-01-30 |
Family
ID=47568138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012103577596A Pending CN102895452A (en) | 2012-09-14 | 2012-09-14 | Oral medicinal liquor for treatment of liver depression and qi stagnation type chloasma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102895452A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101129683A (en) * | 2007-08-23 | 2008-02-27 | 泰维昌 | Orally taken traditional Chinese medicine composition for treating chloasma |
| CN102139034A (en) * | 2011-04-07 | 2011-08-03 | 王勇勤 | Medicament for treating chloasma |
| JP2011190215A (en) * | 2010-03-15 | 2011-09-29 | Shinji Nishida | Drug for improving collagen disease |
-
2012
- 2012-09-14 CN CN2012103577596A patent/CN102895452A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101129683A (en) * | 2007-08-23 | 2008-02-27 | 泰维昌 | Orally taken traditional Chinese medicine composition for treating chloasma |
| JP2011190215A (en) * | 2010-03-15 | 2011-09-29 | Shinji Nishida | Drug for improving collagen disease |
| CN102139034A (en) * | 2011-04-07 | 2011-08-03 | 王勇勤 | Medicament for treating chloasma |
Non-Patent Citations (3)
| Title |
|---|
| 刘冬梅等: "疏肝解郁丸治疗女性肝郁气滞型黄褐斑的作用机制", 《中华中医药杂志》 * |
| 吕曹华等: "解郁消斑汤治疗肝郁气滞型女性黄褐斑30例", 《上海中医药杂志》 * |
| 高景华: "《名医珍藏药酒大全》", 30 April 2012 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101411848B (en) | Black plaster for treating gland hyperplasia and preparation method thereof | |
| CN105030919A (en) | Medicinal composition for treating cerebral hemorrhage | |
| CN102198253A (en) | Traditional Chinese medicine composition for resisting depression, and preparation method as well as application thereof | |
| CN102973785B (en) | Traditional Chinese medicine for treatment of diabetic cardiomyopathy | |
| CN102755424B (en) | A kind of oral medicinal liquor for the treatment of sciatica | |
| CN102895452A (en) | Oral medicinal liquor for treatment of liver depression and qi stagnation type chloasma | |
| CN102743444B (en) | A kind of oral medicinal liquor for the treatment of locality closure traumatic injury | |
| CN102813746B (en) | Traditional Chinese medicine composition for treating numbness of fingers | |
| CN102784222B (en) | A kind of oral medicinal liquor for the treatment of chronic lumbar muscle strain | |
| CN102895309A (en) | Oral medicinal liquor for treating wind-cold tightened exterior type urticaria | |
| CN104353045A (en) | Walnut cream with asthma preventing effect | |
| CN104524235A (en) | Traditional Chinese medicine composition for treating cardiac neurosis | |
| CN102784265B (en) | A kind of oral medicinal liquor for the treatment of shoulder bruise | |
| CN102784296A (en) | Fructus trichosanthis oral liquid | |
| CN102648956A (en) | Traditional Chinese herbal medicament for treating breast cancer and preparation method thereof | |
| CN102727806B (en) | Traditional Chinese medicine for treating aplastic anemia by tonifying qi | |
| CN101129554A (en) | Traditional Chinese medicine for treating sick headache | |
| CN101502597A (en) | Medicament for treating stomachache and preparation method thereof | |
| CN101249250A (en) | Medicinal liquor preparations for curing stagnation and blood stasis chest stuffiness and pain | |
| CN105663416A (en) | Traditional Chinese medicine composition for treating heart blood stasis type chest obstruction and preparation method thereof | |
| CN102846828A (en) | Oral administration medicinal liquor for treating Yin blood deficiency type urticaria | |
| CN104027587A (en) | Traditional Chinese medicine composition for treating psoriasis | |
| CN102784249A (en) | Orally-administrated medicinal liquor for treating sudden lumbar sprain | |
| CN102872196A (en) | Tincture medicament for treating wet beriberi | |
| CN102784285B (en) | A kind of oral medicinal liquor treating asthma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130130 |